| Page 1136 | Kisaco Research
 

Frederique Welgryn

Global Vice President, Women’s Health
Perrigo

Frederique Welgryn is a successful innovation centric executive with 20+ years of experience in Pharma & OTC. Passionate about healthcare and specifically Women's Health, Frederique has been involved or led major Rx-to-OTC programs and launches in Women’s Health in Europe or in the US in the last 10 years. Her team recently conducted the Rx-to-OTC switch of a Progestin Only Pill in the US, which received unanimous support from a joint FDA Advisory Committee Panel in May 2023.

Read full bio

Frederique Welgryn

Global Vice President, Women’s Health
Perrigo

Frederique Welgryn

Global Vice President, Women’s Health
Perrigo

Frederique Welgryn is a successful innovation centric executive with 20+ years of experience in Pharma & OTC. Passionate about healthcare and specifically Women's Health, Frederique has been involved or led major Rx-to-OTC programs and launches in Women’s Health in Europe or in the US in the last 10 years. Her team recently conducted the Rx-to-OTC switch of a Progestin Only Pill in the US, which received unanimous support from a joint FDA Advisory Committee Panel in May 2023.

In January 2023, she initiated the creation of a dedicated Global Women’s Health Division at Perrigo, with a mission to empower women and people to determine and access their own sexual health journey.